E27.1
Primary adrenocortical insufficiency
Clinical Classification Guidelines
Inclusion Terms
- Addison's disease
- Autoimmune adrenalitis
Excludes Type 1
- Addison only phenotype adrenoleukodystrophy (E71.528)
- amyloidosis (E85.-)
- tuberculous Addison's disease (A18.7)
- Waterhouse-Friderichsen syndrome (A39.1)
Medical Intelligence & Overview
Primary adrenocortical insufficiency, commonly known as Addison's disease, is a rare disorder characterized by inadequate production of hormones by the adrenal glands. These glands, located on top of the kidneys, are responsible for producing vital hormones like cortisol and aldosterone. When they fail to produce enough of these hormones, it results in a range of health issues that can affect multiple systems in the body. This condition is most often caused by autoimmune processes, where the body's immune system mistakenly attacks the adrenal glands. Recognizing and understanding this condition is crucial for timely management and improving quality of life.
Causes & Symptoms
Clinical Causes: Autoimmune adrenalitis: The immune system targets and destroys adrenal tissue, leading to hormone deficiency. Genetic predisposition: Certain genetic factors increase susceptibility to autoimmune diseases including Addison's. Infections: Tuberculosis and other infections can damage the adrenal glands. Other causes: Adrenal hemorrhage, metastatic cancer, or genetic disorders may also contribute, though less commonly.
Key Symptoms: Chronic fatigue and weakness Loss of appetite and weight loss Skin hyperpigmentation, especially in scars, skin folds, and pressure points Low blood pressure leading to dizziness or fainting Salt cravings due to loss of aldosterone Nausea, vomiting, and abdominal pain Muscle and joint pain Mood changes or depression Hypoglycemia (low blood sugar)
Diagnostic & Treatment
Diagnosis Path: Diagnosing primary adrenocortical insufficiency involves a combination of clinical evaluation and laboratory tests. Blood tests typically reveal low cortisol levels and elevated levels of adrenocorticotropic hormone (ACTH), reflecting the body's attempt to stimulate the adrenal glands. Additional tests such as the ACTH stimulation test can help confirm the diagnosis by assessing the adrenal glands’ response to stimulation. Imaging studies like CT scans may be utilized to evaluate the size and structure of the adrenal glands and identify any structural abnormalities or damage. The presence of skin hyperpigmentation is also an important clinical clue supporting diagnosis.
Treatment Protocols: Treatment primarily aims to replace the deficient hormones and manage any underlying autoimmune process. Patients often require lifelong hormone replacement therapy that includes glucocorticoids (like hydrocortisone or prednisone) to compensate for cortisol deficiency. Mineralocorticoids (such as fludrocortisone) are prescribed to maintain electrolyte balance and blood pressure. Regular monitoring and dose adjustments are essential, especially during periods of stress or illness, to prevent adrenal crises. Patients are also advised to carry medical identification and emergency hydrocortisone injections in case of severe adrenal crisis. Managing individual health and addressing autoimmune activity when possible are also components of comprehensive care.
Clinical Advice & FAQs
Billing Guidance
Is E27.1 a billable ICD-10 code?
Yes, E27.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E27.1?
Clinical documentation must specify the nature of Primary adrenocortical insufficiency and any associated comorbidities for accurate reporting.
Cite this Clinical Reference